LXEO Latest Press Releases

-- September 2, 2026 --

Lexeo Therapeutics to Participate in Upcoming Investor Conferences in September Globe Newswire 7:00 AM

-- August 12, 2026 --

Lexeo Therapeutics Reports Second Quarter 2026 Financial Results and Operational Highlights Globe Newswire 7:00 AM

-- August 5, 2026 --

Lexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for LX2020 for the Treatment of PKP2 Arrhythmogenic Cardiomyopathy Globe Newswire 7:00 AM

-- June 17, 2026 --

Lexeo Therapeutics Announces Publication in JAMA Cardiology of Phase I/II Data for LX2006 in Friedreich Ataxia Globe Newswire 4:01 PM

-- June 15, 2026 --

Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia Globe Newswire 7:00 AM

-- May 19, 2026 --

Lexeo Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference Globe Newswire 7:00 AM

-- May 11, 2026 --

Lexeo Therapeutics Reports First Quarter 2026 Financial Results and Operational Highlights Globe Newswire 7:00 AM

-- April 27, 2026 --

Lexeo Therapeutics Announces Multiple Presentations at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting Globe Newswire 5:15 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software